Agnes Jager

23PUBLICATIONS
200CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersNanotoxicology, health and safetyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 14, 2025
Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands.

Chiem L de Jong, Gina Schijven, Ellen G Engelhardt

|Sep 04, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Elisabeth M Jongbloed, Noor Wortelboer, Vanja de Weerd

|Feb 21, 2025
Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis.

Michiel Zietse, Thirza Kooijman, Ruben Malmberg

|Feb 17, 2025
Development and validation of a functional ex vivo paclitaxel and eribulin sensitivity assay for breast cancer, the REMIT assay.

Zofia M Komar, Nicole S Verkaik, Ahmed Dahmani

|Feb 10, 2025
Pseudo acute kidney injury in patients receiving CDK4/6 inhibitors.

Sanne M Buijs, Elisabeth M Jongbloed, Lotte E M van Bergen

|Nov 28, 2024
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.

Gabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer

Pageof 4

Frequent Collaborators

4 joint publications

Gabe S Sonke

4 joint publications

Hedwig M Blommestein

3 joint publications

Noor Wortelboer

3 joint publications

Petra Nederlof